Nearly 90% of those in the largest-to-date study of patients with postural orthostatic tachycardia syndrome had elevated levels of a specific autoantibody. The finding both adds significantly to the evidence that POTS is an autoimmune disorder, and identifies a key biomarker that might allow diagnosis with a simple blood test.
Click here for original story, First potential biomarker for a debilitating fainting condition
Source: ScienceDaily